Eon Labs Introduces First Generic Approval to Market With Bisoprolol Fumarate Tablets.
LAURELTON, N.Y.--(BW HealthWire)--Nov. 17, 2000
Eon Labs has introduced Bisoprolol Fumarate, 5mg and 10mg Tablets, the first generic approval to market that is proven to be bioequivalent to the brand Zebeta(R)(1). Sales for the antihypertensive jumped by 68% in the past 12 months as demand has increased(2).
"The introduction of Bisoprolol Fumarate, our third exclusive generic thus far this year, is part of Eon's strategy to be first to market with niche, as well as blockbuster generics", said Frank Della Fera, Vice President of Sales and Marketing for Eon Labs. "Bisoprolol Fumarate is one of many new approvals for Eon Labs as we continue to be one of the most prolific marketers of new ANDA's in the generic industry", concluded Della Fera.
Eon Labs is one of the leading generic pharmaceutical companies in the U.S., widely known as the "Pharmacy Drug Company." For more information on Eon Bisoprolol Fumarate, or other quality products from Eon Labs, call 1-800-526-0225, or write to Eon Labs Manufacturing, Inc., 227-15 N. Conduit Avenue, Laurelton, N.Y., 11413.
Product photo available upon request.
(1) Zebeta is a registered trademark of Lederle Laboratories and is
not affiliated with Eon Labs Manufacturing, Inc.
(2) Source: Scott-Levin, SPA September 2000.
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 17, 2000|
|Previous Article:||Vingage Selected by Siscom as Technology Partner for Management and Delivery of Video Over the Internet.|
|Next Article:||adam.com Chairman and CEO Appears on GPTV Georgia Business Report.|